24 results for “un”
Sean McKinley of Originals CBD explores the emerging dangers of synthetic and semi-synthetic cannabinoids in Europe, both for businesses and consumers.
Since launching its legal support helpline, Releaf Cannabis Clinic has received increasing reports from patients experiencing stigma and discrimination.
Europe’s dedicated medical cannabis education series for clinicians and industry professionals announces two autumn events — 4 November at Mainhaus, Frankfurt, and 26 November at Conway Hall, London
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, […]
Researchers have identified a potential mechanism linked to a reduced risk of type 2 diabetes.
YouGov has published a representative survey examining the British public’s attitudes towards cannabis.
Two non-psychoactive cannabis compounds may help treat the most common form of chronic liver disorder.
The Hannah Deacon Campaign is calling on the government to support children unable to access medical cannabis on the NHS.
Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine.
Researchers say the new thresholds – modelled on alcohol units – could help people avoid potentially harmful consumption.
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
Curaleaf Laboratories’ sponsorship forms part of its ongoing collaboration with the MCCS.
A new report from the General Pharmaceutical Council’s (GPhC) provides the most detailed regulatory snapshot yet of how medical cannabis is being dispensed across the UK.
The conversation around workers’ rights and medical cannabis is still at a very early stage in the UK.
New analysis has found that NHS access to medical cannabis could help thousands of patients with chronic conditions return to work.
Curaleaf Laboratories, part of Curaleaf International, today announced the UK launch of the Curaleaf Que Medical Inhalation Device (QMID), the first CE-certified liquid inhaler for cannabis-based medicines. Available on prescription, […]
Cannabis Health will host its first expert-led educational event for healthcare professionals later this year.
Dr Sue Clenton, Medical Director at Releaf explores the role that clinics can play in recruiting and training the next generation of medical cannabis professionals.
Researchers from Stellenbosch University have found evidence of rare phenolic compounds in cannabis leaves.
Ministers raised concerns related to the growing use among young people and potential risks to mental health.
Data collected from 25,000 older adults shows cannabis use may be linked to slower brain ageing and improved cognitive function.
A cancer patient, using medical cannabis to manage the side effects of chemotherapy, developed a life-threatening fungal infection after using a contaminated product.
By Dr Sue Clenton, Medical Director, Rupa Shah, Chief Legal and Compliance Officer, and Graham Woodward, Chief Operations Officer, Releaf In a healthcare landscape as tightly regulated as the UK’s […]
Campaigners are urging lawmakers to consider the challenges facing people who rely on access for medical purposes.
